SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-115162
Filing Date
2012-03-14
Accepted
2012-03-14 17:16:56
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d262743d10k.htm 10-K 856530
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d262743dex23.htm EX-23 2213
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION d262743dex311.htm EX-31.1 6918
4 SECTION 1350 CERTIFICATION d262743dex32.htm EX-32 3636
11 GRAPHIC g262743g90d27.jpg GRAPHIC 38413
  Complete submission text file 0001193125-12-115162.txt   3394372

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nabi-20111231.xml EX-101.INS 506846
6 XBRL TAXONOMY EXTENSION SCHEMA nabi-20111231.xsd EX-101.SCH 14976
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nabi-20111231_cal.xml EX-101.CAL 35432
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nabi-20111231_def.xml EX-101.DEF 19513
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nabi-20111231_lab.xml EX-101.LAB 154988
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nabi-20111231_pre.xml EX-101.PRE 100786
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
Type: 10-K | Act: 34 | File No.: 001-35285 | Film No.: 12691103
SIC: 2836 Biological Products, (No Diagnostic Substances)